Literature DB >> 6831169

The reasons for persistent hypercalcaemia after cervical exploration for presumed primary hyperparathyroidism.

C F Russell, A J Edis, D C Purnell.   

Abstract

Of 500 consecutive patients who underwent cervical exploration for presumed primary hyperparathyroidism, 461 (92.2 per cent) were cured, as judged by an immediate return of serum calcium levels to normal. Thirty-nine patients (7.8 per cent) had persistent hypercalcaemia after the initial operation. The clinical profiles, operative and pathologic findings, surgical procedures performed and subsequent management of these 39 patients were reviewed. At reevaluation, 4 patients were noted to have been cured of their hyperparathyroidism. Twenty-one patients had persistent hyperparathyroidism: in 6, all 4 parathyroid glands had not been identified at the initial operation and in 15, hypercalcaemia persisted after the identification of 4 glands. One patient had recurrent hyperparathyroidism after the removal of a 720 mg adenoma and the identification of 3 normal parathyroid glands. Nine patients had nonparathyroid causes for the hypercalcaemia: 2 had occult malignant neoplasms, 6 had benign familial hypocalciuric hypercalcaemia and 1 had immobilization hypercalcaemia. In 4 patients the reason for the persistent hypercalcaemia remained unclear. We suggest a schema that may be used as a guideline in the investigation and management of patients with persistent hypercalcaemia after primary neck exploration for presumed hyperparathyroidism.

Entities:  

Mesh:

Year:  1983        PMID: 6831169     DOI: 10.1002/bjs.1800700404

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  2 in total

1.  Persistent hypercalcemia after neck exploration--an analysis of 34 cases.

Authors:  A Kristoffersson; L Boquist; J Järhult
Journal:  Urol Res       Date:  1986

2.  Recurrent hyperparathyroidism: a study of 3 cases with evaluation of some pathogenetic and clinical aspects.

Authors:  G Mazzuoli; S Minisola; A Scarda; A De Matteis; S Tabolli; F Bigi; C Valtorta; E D'Erasmo
Journal:  Postgrad Med J       Date:  1987-03       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.